Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Avalo Therapeutics, Inc. | cercex-3212019.htm |
| EX-31.2 - EXHIBIT 31.2 - Avalo Therapeutics, Inc. | cercex-3122019.htm |
| EX-31.1 - EXHIBIT 31.1 - Avalo Therapeutics, Inc. | cercex-3112019.htm |
| EX-23.1 - EXHIBIT 23.1 - Avalo Therapeutics, Inc. | cercex-2312019.htm |
| EX-10.32 - EXHIBIT 10.32 - Avalo Therapeutics, Inc. | ex-1032assignmentoflicense.htm |
| EX-10.15.2 - EXHIBIT 10.15.2 - Avalo Therapeutics, Inc. | ex-10152amendmenttoharrell.htm |
| EX-4.10 - EXHIBIT 4.10 - Avalo Therapeutics, Inc. | ex-410descriptionofregiste.htm |
| 10-K - 10-K - Avalo Therapeutics, Inc. | cerc10-k20191231.htm |
Exhibit 21.1
List of Subsidiaries of Cerecor Inc.
Entity Name | Jurisdiction |
Ichorion Therapeutics, LLC | Delaware |
Aevi Genomic Medicine, LLC | Delaware |
Medgenics Medical (Israel) Ltd. | State of Israel |
neuroFix, LLC | Delaware |
Aevi Genomic Medicine Europe BVBA/SPRL | Belgium |
TRx Pharmaceuticals, LLC | North Carolina |
Zylera Pharmaceuticals, LLC | North Carolina |
Zylera Pharma Corp. | North Carolina |